Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

19.75
Delayed Data
As of Sep 02
 +0.92 / +4.89%
Today’s Change
7.31
Today|||52-Week Range
23.30
+137.95%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Supernus Pharmaceuticals Inc have a median target of 23.50, with a high estimate of 35.00 and a low estimate of 20.00. The median estimate represents a +18.99% increase from the last price of 19.75.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Supernus Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.03
Sales
$37.9M
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -25.00%
 
 
 
 
 
 
Growthannually -52.08%
 
 
 
 
 
 

Sales

Growthquarterly 8.10%
 
 
 
 
 
 
Growthannually 16.55%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.